Company Filing History:
Years Active: 2018
Title: Michael Höpfner: Innovator in HDAC Inhibitors
Introduction
Michael Höpfner is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of HDAC inhibitors. His innovative work has led to the creation of a unique compound that has potential therapeutic applications.
Latest Patents
Höpfner holds a patent for a 4,5-diarylimidazole derivative, which is described as having a hydroxamic acid residue at a first aryl ring and a residue R1 at a second aryl ring. The patent outlines the structural formulae and various chemical properties of the compound, which may serve as a valuable tool in medical treatments. He has 1 patent to his name.
Career Highlights
Throughout his career, Michael Höpfner has worked with prestigious institutions such as Charité-Universitätsmedizin Berlin and Universität Bayreuth. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Höpfner has collaborated with notable colleagues, including Bernhard Max Biersack and Rainer Schobert. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Michael Höpfner's contributions to the field of HDAC inhibitors exemplify the importance of innovation in pharmaceuticals. His work continues to inspire future research and development in this critical area of medicine.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.